Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403
Clinical trial NCT00655824 · TERMINATED
Trial details
- NCT number
- NCT00655824
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2011-05-25
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.